Vasospastic Angina
16
6
6
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
19%
3 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (16)
iCorMicA - Stratified Medicine in Angina
POLish Registry of CArdioneuroablation and CArdioneuromodulation
Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic
The Impact of Vericiguat on Microvascular Function in Patients with Documented Vasospastic Angina Pectoris
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Immunomodulatory Therapy & VSA
Transcutaneous Electrical Nerve Stimulation in Patients With Angina and Non-Obstructive Coronary Arteries
Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Coronary Syndrome and no Significant Coronary Artery Stenosis
Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease
A Multi-Omics Study of Vasospastic Angina
Myocardial Ischemia Without Obstructive Coronary Stenoses
Multidetector Coronary CT In Vasospastic Angina
Bioequivalency Study of Amlodipine Tablets Under Fed Conditions
Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions
A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina
Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina